Alpine Immune Sciences Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 85
Employees
  • Stock Symbol
  • ALPN
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $8.25
  • (As of Friday Closing)

Alpine Immune Sciences General Information

Description

Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 188 East Blaine Street
  • Suite 200
  • Seattle, WA 98102
  • United States
+1 (206) 000-0000

Alpine Immune Sciences Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alpine Immune Sciences Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.25 $8.01 $6.00 - $14.40 $250M 30.3M 106K -$1.78

Alpine Immune Sciences Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 129,066 245,173 181,110 41,025
Revenue 33,868 23,443 9,335 1,740
EBITDA (46,285) (49,243) (26,838) (42,294)
Net Income (47,217) (50,333) (27,940) (41,852)
Total Assets 233,938 255,900 144,090 54,093
Total Debt 18,299 19,628 22,598 16,356
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Alpine Immune Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alpine Immune Sciences‘s full profile, request access.

Request a free trial

Alpine Immune Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Alpine Immune Sciences‘s full profile, request access.

Request a free trial

Alpine Immune Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing in
Pharmaceuticals
Seattle, WA
85 As of 2021
00000
000000000 00000

00000000

ud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in re
0000000000000
Vancouver, Canada
000 As of 0000
00000
0000 0000-00-00
000000000000

00000000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non p
000000000000000
Tarrytown, NY
00000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alpine Immune Sciences Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zymeworks Formerly VC-backed Vancouver, Canada 000 00000 000000000000
000000000 00000000 Formerly VC-backed Tarrytown, NY 00000 00000 00000000000 00000
00000000000 Formerly VC-backed Rockville, MD 000 00000 000000000 00000
00000000 0000 Formerly VC-backed Austin, TX 00 00000 00000000 00000
000000 Formerly VC-backed Monrovia, CA 000 00000 00000000 00000
You’re viewing 5 of 5 competitors. Get the full list »

Alpine Immune Sciences Patents

Alpine Immune Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210363223-A1 April and baff inhibitory immunomodulatory proteins and methods of use thereof Pending 08-May-2020 000000000000
AU-2020257238-A1 Methods and uses of variant icos ligand (icosl) fusion proteins Pending 17-Apr-2019 00000000000
CA-3136816-A1 Methods and uses of variant icos ligand (icosl) fusion proteins Pending 17-Apr-2019 00000000000
CA-3120868-A1 Cd86 variant immunomodulatory proteins and uses thereof Pending 30-Nov-2018 000000000000
EP-3887394-A2 Cd86 variant immunomodulatory proteins and uses thereof Pending 30-Nov-2018 C07K14/70532
To view Alpine Immune Sciences’s complete patent history, request access »

Alpine Immune Sciences Executive Team (10)

Name Title Board Seat Contact Info
Mitchell Gold MD Chief Executive Officer & Chairman
Stanford Peng Ph.D Executive & President
Paul Rickey Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Remy Durand Ph.D Chief Business Officer
Zelanna Goldberg MD Chief Medical Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Alpine Immune Sciences Board Members (10)

Name Representing Role Since
Christopher Peetz Self Board Member 000 0000
James Topper Ph.D Self Board Member 000 0000
Jay Venkatesan MD Self Board Member 000 0000
Mitchell Gold MD Alpine Immune Sciences Chief Executive Officer & Chairman 000 0000
Natasha Hernday Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Alpine Immune Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alpine Immune Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Alpine Immune Sciences‘s full profile, request access.

Request a free trial

Alpine Immune Sciences Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 24-Jul-2017 0000000000 0000 Biotechnology 00000000
To view Alpine Immune Sciences’s complete acquisitions history, request access »